Kraken Red Borneo Capsules

Kraken Red Borneo Capsules demonstrate a solid overall quality assessment, reflected in their transparency score of 85/100, which indicates a commendable level of product transparency and testing rigor. The completeness of the Certificate of Analysis (COA) received a perfect score, ensuring consumers have access to comprehensive information regarding the product's composition. However, the potency consistency score of 23/30 suggests variability in the levels of active compounds across the two batches analyzed, which may affect user experience. The average mitragynine content of 1.38% is within the expected range for red vein kratom strains, but it is important to note that the cost per 100mg of mitragynine is $4.33, significantly higher than the market median of $2.32. This price point raises concerns regarding value for money, particularly for consumers seeking effective kratom products at competitive prices. Safety assessments indicate that all contaminant tests passed, and the heavy metal safety score of 17.5/20 reflects a strong commitment to consumer safety. The lab credibility score of 13.5/15 further supports the reliability of the testing processes employed. While the product shows promise in terms of safety and transparency, potential buyers should weigh the high cost against the potency consistency and overall market alternatives. In conclusion, Kraken Red Borneo Capsules offer a reliable option for kratom users who prioritize safety and transparency. However, the high price relative to the average potency may deter budget-conscious consumers. For those willing to invest in quality, this product may still be worth considering, but it is advisable to explore other options that may provide better value for similar potency levels.